Literature DB >> 3426243

Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult rat heart cells.

C Hohl1, R Oestreich, P Rösen, R Wiesner, M Grieshaber.   

Abstract

It has been demonstrated that perfusion of myocardium with glutamic acid or tricarboxylic acid cycle intermediates during hypoxia or ischemia, improves cardiac function, increases ATP levels, and stimulates succinate production. In this study isolated adult rat heart cells were used to investigate the mechanism of anaerobic succinate formation and examine beneficial effects attributed to ATP generated by this pathway. Myocytes incubated for 60 min under hypoxic conditions showed a slight loss of ATP from an initial value of 21 +/- 1 nmol/mg protein, a decline of CP from 42 to 17 nmol/mg protein and a fourfold increase in lactic acid production to 1.8 +/- 0.2 mumol/mg protein/h. These metabolite contents were not altered by the addition of malate and 2-oxoglutarate to the incubation medium nor were differences in cell viability observed; however, succinate release was substantially accelerated to 241 +/- 53 nmol/mg protein. Incubation of cells with [U-14C]malate or [2-U-14C]oxoglutarate indicates that succinate is formed directly from malate but not from 2-oxoglutarate. Moreover, anaerobic succinate formation was rotenone sensitive. We conclude that malate reduction to succinate occurs via the reverse action of succinate dehydrogenase in a coupled reaction where NADH is oxidized (and FAD reduced) and ADP is phosphorylated. Furthermore, by transaminating with aspartate to produce oxaloacetate, 2-oxoglutarate stimulates cytosolic malic dehydrogenase activity, whereby malate is formed and NADH is oxidized. In the form of malate, reducing equivalents and substrate are transported into the mitochondria where they are utilized for succinate synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426243     DOI: 10.1016/0003-9861(87)90519-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  Transport and metabolism of exogenous fumarate and 3-phosphoglycerate in vascular smooth muscle.

Authors:  D R Finder; C D Hardin
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

2.  Relations between the energy state of the myocardium and release of some products of anaerobic metabolism during underperfusion.

Authors:  O I Pisarenko; I M Studneva; V S Shulzhenko; V I Kapelko
Journal:  Pflugers Arch       Date:  1990-06       Impact factor: 3.657

Review 3.  Inhibitors of succinate: quinone reductase/Complex II regulate production of mitochondrial reactive oxygen species and protect normal cells from ischemic damage but induce specific cancer cell death.

Authors:  Stephen J Ralph; Rafael Moreno-Sánchez; Jiri Neuzil; Sara Rodríguez-Enríquez
Journal:  Pharm Res       Date:  2011-08-24       Impact factor: 4.200

4.  Astrocytic amino acid metabolism under control conditions and during oxygen and/or glucose deprivation.

Authors:  Leif Hertz
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

5.  Effect of pyruvate on rat heart thiol status during ischemia and hypoxia followed by reperfusion.

Authors:  M P Rigobello; A Bindoli
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

6.  O(2)-sensing signal cascade: clamping of O(2) respiration, reduced ATP utilization, and inducible fumarate respiration.

Authors:  Vijayalakshmi Sridharan; Jason Guichard; Chuan-Yuan Li; Robin Muise-Helmericks; Craig Cano Beeson; Gary L Wright
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-07       Impact factor: 4.249

7.  Transcriptional Regulation of SDHa flavoprotein by nuclear respiratory factor-1 prevents pseudo-hypoxia in aerobic cardiac cells.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

8.  Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.

Authors:  Houman Ashrafian; Gabor Czibik; Mohamed Bellahcene; Dunja Aksentijević; Anthony C Smith; Sarah J Mitchell; Michael S Dodd; Jennifer Kirwan; Jonathan J Byrne; Christian Ludwig; Henrik Isackson; Arash Yavari; Nicolaj B Støttrup; Hussain Contractor; Thomas J Cahill; Natasha Sahgal; Daniel R Ball; Rune I D Birkler; Iain Hargreaves; Daniel A Tennant; John Land; Craig A Lygate; Mogens Johannsen; Rajesh K Kharbanda; Stefan Neubauer; Charles Redwood; Rafael de Cabo; Ismayil Ahmet; Mark Talan; Ulrich L Günther; Alan J Robinson; Mark R Viant; Patrick J Pollard; Damian J Tyler; Hugh Watkins
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

9.  Comparison of Malated Ringer's with Two Other Balanced Crystalloid Solutions in Resuscitation of Both Severe and Moderate Hemorrhagic Shock in Rats.

Authors:  Judith Keitel; Bjoern Hussmann; Sven Lendemans; Herbert de Groot; Ricarda Rohrig
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

10.  PK11195 Protects From Cell Death Only When Applied During Reperfusion: Succinate-Mediated Mechanism of Action.

Authors:  Lea K Seidlmayer; Benjamin J Hanson; Phung N Thai; Saul Schaefer; Donald M Bers; Elena N Dedkova
Journal:  Front Physiol       Date:  2021-05-04       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.